FDA Classifies Genetic Health Risk Assessment System into Class II Special Controls

Summary

The FDA has classified the genetic health risk assessment system into Class II special controls, aiming to ensure device safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.